Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.

Baumann T, Delgado J, Santacruz R, Martínez-Trillos A, Royo C, Navarro A, Pinyol M, Rozman M, Pereira A, Villamor N, Aymerich M, López C, Carrió A, Montserrat E.

Haematologica. 2014 Oct;99(10):1599-604. doi: 10.3324/haematol.2014.107326.

2.

CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

Del Poeta G, Del Principe MI, Zucchetto A, Luciano F, Buccisano F, Rossi FM, Bruno A, Biagi A, Bulian P, Maurillo L, Neri B, Bomben R, Simotti C, Coletta AM, Dal Bo M, de Fabritiis P, Venditti A, Gattei V, Amadori S.

Haematologica. 2012 Feb;97(2):279-87. doi: 10.3324/haematol.2011.052829.

3.

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.

Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov DG, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L.

J Transl Med. 2012 Jan 30;10:18. doi: 10.1186/1479-5876-10-18.

4.

Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.

Xu M, Fan L, Miao KR, Liu P, Xu W, Li JY.

Med Oncol. 2012 Sep;29(3):2102-10. doi: 10.1007/s12032-011-0054-2.

PMID:
21881978
5.

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes.

Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Schwager SM, Bowen DA, Conte M, Jelinek DF, Slager SL, Shanafelt TD.

Haematologica. 2014 Jan;99(1):140-7. doi: 10.3324/haematol.2013.086066.

6.

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Mosca L, Matis S, Fabris S, Lionetti M, Ilariucci F, Zupo S, Musolino C, Levato L, Molica S, Di Raimondo F, Vincelli I, Di Rienzo N, Pesce EA, Angrilli F, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2014 Jul;89(7):743-50. doi: 10.1002/ajh.23729.

7.

Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.

Zou ZJ, Fan L, Wang L, Zhang R, Zhang LN, Yang S, Li JY, Xu W.

Cancer Biomark. 2012;12(4):169-76. doi: 10.3233/CBM-130304.

PMID:
23568007
8.

The clinical significance of patients' sex in chronic lymphocytic leukemia.

Catovsky D, Wade R, Else M.

Haematologica. 2014 Jun;99(6):1088-94. doi: 10.3324/haematol.2013.101378.

9.

Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.

Oliveira AC, de la Banda E, Domingo-Domenech E, Encuentra M, Mercadal S, Domingo A, Alonso E, Espinet B, Grau J, De Sevilla AF, Gonzalez-Barca E.

Leuk Lymphoma. 2011 Mar;52(3):429-35. doi: 10.3109/10428194.2010.545463.

PMID:
21323523
10.

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, Bomben R, Dal-Bo M, Luciano F, Rossi FM, Degan M, Amadori S, Del Poeta G.

Blood. 2008 Jan 15;111(2):865-73.

11.

The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.

Karmiris T, Rohatiner AZ, Love S, Carter M, Ganjoo RK, Amess J, Norton AJ, Lister TA.

Hematol Oncol. 1994 Jan-Feb;12(1):29-39.

PMID:
7515019
12.

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.

Santacruz R, Villamor N, Aymerich M, Martínez-Trillos A, López C, Navarro A, Rozman M, Beà S, Royo C, Cazorla M, Colomer D, Giné E, Pinyol M, Puente XS, López-Otín C, Campo E, López-Guillermo A, Delgado J.

Haematologica. 2014 May;99(5):873-80. doi: 10.3324/haematol.2013.099796.

13.

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.

Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D.

Blood. 1996 Dec 1;88(11):4259-64.

14.

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.

Kaderi MA, Kanduri M, Buhl AM, Sevov M, Cahill N, Gunnarsson R, Jansson M, Smedby KE, Hjalgrim H, Jurlander J, Juliusson G, Mansouri L, Rosenquist R.

Haematologica. 2011 Aug;96(8):1153-60. doi: 10.3324/haematol.2010.039396.

15.

Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.

Molica S, Digiesi G, Battaglia C, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Gentile M, Morabito F, Ferrarini M.

Eur J Haematol. 2010 Oct;85(4):314-20. doi: 10.1111/j.1600-0609.2010.01482.x.

PMID:
20546021
16.

The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.

Molica S, Mauro FR, Callea V, Giannarelli D, Lauria F, Rotoli B, Cortelezzi A, Liso V, Foà R.

Haematologica. 2010 Mar;95(3):464-9. doi: 10.3324/haematol.2009.011767.

17.

Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.

Molica S, Digiesi G, Mirabelli R, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Morabito F, Neri A, Baldini L, Ferrarini M.

Eur J Haematol. 2009 Sep;83(3):208-14. doi: 10.1111/j.1600-0609.2009.01273.x.

PMID:
19459926
18.

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia.

Perbellini O, Falisi E, Giaretta I, Boscaro E, Novella E, Facco M, Fortuna S, Finotto S, Amati E, Maniscalco F, Montaldi A, Alghisi A, Aprili F, Bonaldi L, Paolini R, Scupoli MT, Trentin L, Ambrosetti A, Semenzato G, Pizzolo G, Rodeghiero F, Visco C.

Haematologica. 2014 May;99(5):881-7. doi: 10.3324/haematol.2013.096362.

19.

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.

Bairey O, Ruchlemer R, Rahimi-Levene N, Herishanu Y, Braester A, Berrebi A, Polliack A, Klepfish A, Shvidel L; Israeli CLL Study Group (ICLLSG)..

Ann Hematol. 2011 Oct;90(10):1123-9. doi: 10.1007/s00277-011-1259-3. Review.

PMID:
21614458
20.

[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].

Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.

Acta Med Croatica. 2008 Oct;62(4):351-64. Croatian.

PMID:
19205412
Items per page

Supplemental Content

Support Center